Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography
- PMID: 35166445
- DOI: 10.1111/vco.12805
Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography
Abstract
Few studies have investigated the diagnostic performance of fluorine-18-fluorodeoxyglucose (18 F-FDG) positron emission tomography/computed tomography (PET/CT) for staging veterinary patients with appendicular osteosarcoma. The purpose of this study was to evaluate the efficacy of 18 F-FDG-PET/CT compared to whole-body CT (WBCT) for staging canine patients with appendicular osteosarcoma. The 18 F-FDG-PET/CT imaging studies of 66 dogs with appendicular osteosarcoma were anonymized and separated into two detached studies (one with whole body pre- and post-contrast CT images and the other with the whole body pre- and post-contrast CT images with the associated 18 F-FDG-PET overlay). Image assessment was performed retrospectively by five board-certified veterinary radiologists. The radiologists were instructed to assign a predefined categorical score (1-4) to each pre-designated anatomic region based on a devised lesional scoring system. A score of 1 was normal, 2 abnormal but not neoplastic, 3 abnormal and concerning for neoplasia, and 4 abnormal, most likely neoplastic. Overall, the likelihood of detection of '3 or 4' was found to be significantly higher with 18 F-FDG PET/CT when compared to WBCT after adjusting for the effect of evaluator and the subject. Most significantly, 13 osseous lesions concerning for metastasis (scored 3-4) were identified in 10/66 dogs by at least one reviewer on 18 F-FDG PET/CT, which were not identified by any reviewer on WBCT. Additionally, four comorbid neoplastic lesions were identified with 18 F-FDG PET/CT and not with WBCT. The results of this study suggest that 18 F-FDG PET/CT is more efficacious in detecting metastatic and comorbid neoplastic lesions compared to WBCT in dogs with appendicular osteosarcoma.
Keywords: CT; FDG; PET/CT; dog; metastasis.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
The use of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography as an effective method for staging in dogs with primary appendicular osteosarcoma.Vet Radiol Ultrasound. 2021 May;62(3):350-359. doi: 10.1111/vru.12959. Epub 2021 Feb 24. Vet Radiol Ultrasound. 2021. PMID: 33629412
-
Retrospective analysis of use of fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG PET/CT) for detection of metastatic lymph nodes in dogs diagnosed with appendicular osteosarcoma.Can J Vet Res. 2021 Apr;85(2):131-136. Can J Vet Res. 2021. PMID: 33883821 Free PMC article.
-
Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET/CT) in dogs with appendicular osteosarcoma before and after stereotactic body radiation therapy (SBRT) and carboplatin chemotherapy to assess for prediction of survival and therapeutic effectiveness.Vet Radiol Ultrasound. 2024 Jul;65(4):408-416. doi: 10.1111/vru.13361. Epub 2024 Apr 24. Vet Radiol Ultrasound. 2024. PMID: 38655687
-
Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.Medicine (Baltimore). 2015 Sep;94(36):e1462. doi: 10.1097/MD.0000000000001462. Medicine (Baltimore). 2015. PMID: 26356700 Free PMC article.
-
18F-FDG PET/CT in the Management of Osteosarcoma.J Nucl Med. 2023 Jun;64(6):842-851. doi: 10.2967/jnumed.123.265592. Epub 2023 May 18. J Nucl Med. 2023. PMID: 37201958 Review.
Cited by
-
Modern applications of positron emission tomography/computed tomography (PET/CT) imaging in veterinary oncology - A brief overview.Can Vet J. 2024 Nov;65(11):1185-1188. Can Vet J. 2024. PMID: 39494176 Free PMC article. No abstract available.
References
REFERENCES
-
- Dorfman SK, Hurvitz AI, Patnaik AK. Primary and secondary bone tumours in the dog. J Small Anim Pract. 1977;18:313-326.
-
- Oblak ML, Boston SE, Woods JP, Nykamp S. Comparison of concurrent imaging modalities for staging of dogs with appendicular primary bone tumours. Vet Comp Oncol. 2015;13:28-39.
-
- Talbott JL, Boston SE, Milner RJ, et al. Retrospective evaluation of whole body computed tomography for tumor staging in dogs with primary appendicular osteosarcoma. Vet Surg. 2017;46(1):75-80.
-
- Crooks C, Randall E, Griffin L. The use of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography as an effective method for staging in dogs with primary appendicular osteosarcoma. Vet Radiol Ultrasound. 2021;62(3):350-359.
-
- Martin TW, Griffin L, Custis J, et al. Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs. Vet Comp Oncologia. 2021;19(2):284-294.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical